The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
A recombinant, bivalent, human papillomavirus (HPV) vaccine, containing virus-like particles for HPV types 16 and 18 linked to the adjuvant ASO4, with potential immunoprotective and antineoplastic properties. Upon administration, HPV 16/18 L1 virus-like particle/ASO4 vaccine may generate humoral and cellular immunity against HPV types-16 and -18 antigens, thereby preventing cervical infection upon exposure to HPV types 16 and 18. In addition, this agent may stimulate an antitumoral cellular immune response against cervical cancer associated with HPV infection. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Cervarix | |
| |||
| Foreign brand name: | | Cervarix | |
| |||
| Abbreviation: | | HPV 16/18 L1 VLP/AS04 VAC | |
| |||
| Code name: | | GSK-580299 | |
| |||
